Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

TGTXTGTX
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in TG Therapeutics, Inc.

BNP PARIBAS FINANCIAL MARKETS holds 860,500 shares of TGTX (TG Therapeutics, Inc.), worth $47.3M as of 2026-Q2. The position was decreased (-10.1% shares). TGTX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$47.3M

Current Shares

860,500

Total Value Change

+$44.5M

Total Shares Change

+742,515

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
860,500
-10.1%
$47.3M0.0%$54.94
0
2026-Q1
Increased
957,026
+40.0%
$31.8M0.0%$28.88
38
2025-Q4
Increased
683,653
+856.6%
$20.4M0.0%$29.75
46
2025-Q3
Decreased
71,464
-9.5%
$2.6M0.0%$36.83
0
2025-Q2
Decreased
78,980
-85.7%
$2.8M0.0%$36.72
0
2025-Q1
Increased
551,029
+822.8%
$21.7M0.0%$39.86
46
2024-Q4
Decreased
59,710
-49.4%
$1.8M0.0%$31.44
0
2024-Q3
Decreased
117,985
-17.3%
$2.8M0.0%$23.83
0

Other major holders of TGTX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used